KeyBank National Association’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$234K Hold
8,135
﹤0.01% 1075
2025
Q1
$273K Sell
8,135
-1,217
-13% -$40.8K ﹤0.01% 1004
2024
Q4
$478K Buy
9,352
+1,176
+14% +$60.1K ﹤0.01% 805
2024
Q3
$418K Buy
8,176
+6
+0.1% +$307 ﹤0.01% 856
2024
Q2
$366K Buy
8,170
+489
+6% +$21.9K ﹤0.01% 861
2024
Q1
$360K Buy
7,681
+235
+3% +$11K ﹤0.01% 881
2023
Q4
$265K Buy
+7,446
New +$265K ﹤0.01% 960